Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 865-870

  Mastaï, Ricardo ^a,b   Laganière, Sylvie ^a,b   Wanless, Ian R ^c   Giroux, Lise ^a,b   Rocheleau, Bernard ^a,b   Huet, Pierre Michel ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENAZONE; CHOLESTEROL; DIETHYLSTILBESTROL; INDOCYANINE GREEN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL INTAKE; CONTROLLED STUDY; HEMODYNAMICS; LIVER BLOOD FLOW; LIVER CLEARANCE; LIVER FIBROSIS; MALE; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RABBIT; XENOBIOTIC METABOLISM;

EID: 0029786855     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855189     Document Type: Article

References (41)

1. Huet PM, Villeneuve JP. Determinants of drug disposition in patients with cirrhosis. HEPATOLOGY 1983;3:913-918.
2. Hoyumpa AM, Schenker S. Influence of liver disease on the disposition and elimination of drugs. In: Schiff L, Schiff ER, eds. Diseases of the Liver. 7th ed. Philadelphia, PA: J.B. Lippincott; 1993:784-824.
3. Fenyves D, Huet PM, Villeneuve JP. Hepatic circulation in cirrhosis. In: Bomzon A, Blendis LM, eds. Cardiovascular Complications of Liver Disease. Boston, MA: CRC Press; 1990:151-178.
4. Schaffner F, Popper H. Capillarization of hepatic sinusoids. Gastroenterology 1963;44:239-242.
5. Bomzon A, Blendis LM. Animal models of liver disease. In: Bomzon A, Blendis LM, eds. Cardiovascular Complications of Liver Disease. Boston, CRC Press, 1990:9-28.
6. Lee SS, Girod C, Valla D, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol 1986;251:G176-G180.
7. Better OS, Massry SG. Effect of chronic bile duct obstruction on renal handling of salt and water. J Clin Invest 1972;51:402-411.
8. Bosch J, Enriguez R, Groszmann RJ, Storer EM. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model. HEPATOLOGY 1983;3:1002-1007.
9. Willems B, Villeneuve JP, Huet PM. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation. HEPATOLOGY 1986;6:92-97.
10. Vorobioff J, Bredfeldt J, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984;87:1120-1126.
11. Varin F, Huet PM. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest 1985;76:1904-1912.
12. 4 an adequate model of human cirrhosis? HEPATOLOGY 1983;3:112-120.
13. Reichen J, Egger B, Ohara N, Beltner B, Zysset T, Zimmermann A. Determinants of hepatic function in liver cirrhosis in the rat. J Clin Invest 1988; 82:2069-2076.
14. Huet PM, Pomier-Layrargues G, Villeneuve JP, Varin F, Viallet A. Intrahepatic microcirculation in liver disease. Semin Liver Dis 1986;6:277-286.
15. Numano F, Katsu K, Kitta T, Shimamoto T. Banti-like syndrome induced by estrogen and cholesterol. Acta Hepato-Splenologica 1969;16:77-85.
16. Wanless IR. Dipyridamole inhibits hepatic fibrogenesis in a rabbit model of cirrhosis. HEPATOLOGY 1981;1:558. Abstract.
17. Wanless IR, Belgiorno J, Huet PM. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit. 1. Morphology and inhibition of fibrogenesis by dipyridamole. HEPATOLOGY 1996;24:855-864.
18. Rappaport PL, Thiessen JJ. High-pressure liquid chromatographic analysis of indocyanine green. J Pharm Sci 1982;71:157-161.
19. 14C-aminopyrine breath test. A comparison of different forms of analysis. Br J Clin Pharmacol 1979;8:539-545.
20. Neutze J, Wyler F, Rudolph A. Use of radioactive microspheres to assess distribution of cardiac output in rabbits. Am J Physiol 1968;215:486-495.
21. Pere M, Gilbert M, Assan R, Battaglia FC. Studies of gut and hepatic metabolism in conscious rabbits. Am J Physiol 1987;252:E573-E580.
22. Mastaï R, Giroux L, Semret M, Huet PM. Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats. Gastroenterology 1990; 98:141-145.
23. Hadengue A, Lee SS, Koshy A, Girod C, Lebrec D. Regional blood flows by the microsphere method: reproducibility in portal hypertensive rats and influence of a portal vein catheter. Proc Soc Exp Biol Med 1988;187: 461-468.
24. Chojkier M, Groszmann RJ. Measurement of portal systemic shunting in the rat using gamma-labeled microspheres. Am J Physiol 1981;240:G371-G375.
25. Lopez-De Lèon A, Rojkind MA. A simple micromethod for collagen and total protein determination in formalin-fixed parraffin-embedded sections. J Histochem Cytochem 1985;33:737-743.
26. Gascon-Barré M, Huet PM, Belgiorno J, Plourde V, Coulombe PA. Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats. J Histochem Cytochem 1989;37:377-381.
27. Lautt W, Greenway C. Conceptual review of the hepatic vascular bed. HEPATOLOGY 1987;7:952-963.
28. Abelmann WH. Hyperdynamic circulation in cirrhosis: a historical perspective. HEPATOLOGY 1994;20:1356-1358.
29. Bruix J, Bosch J, Kravetz D, Mastaï R, Rodes J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology 1985;88:430-435.
30. Benoit JN, Zimmerman B, Premen AJ, Go VLW, Granger DN. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986;251:G674-G677.
31. Ohkubo H, Okuda K, Iida S, Ohnishi K, Ikawa S, Makino I. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acid in liver cirrhosis. Gastroenterology 1984;86:514-520.
32. Groszmann RJ. Hyperdynamic circulation in liver disease 40 years later: pathophysiology and clinical consequences. HEPATOLOGY 1994;20:1359-1363.
33. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776-778.
34. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. HEPATOLOGY 1994;20:1343-1349.
35. Bateman JC, Shorr HM, Elgvin T. Hypervolumic anemia in cirrhosis. J Clin Invest 1948;28:539-547.
36. Bircher J, Kupfer A, Gikalow I, Preisig R. Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther 1976;20: 484-492.
37. Reichen J, Arts B, Schafroth U, Zimmermann A, Beltner B, Zysset T. Aminopyrine N-demethylation by rats with liver cirrhosis, evidence for the intact cell hypothesis, a morphometric-functional study. Gastroenterology 1987;93:719-726.
38. Villeneuve JP, Wood A, Shand D, Rogers L, Branch RA. Impaired drug metabolism in experimental cirrhosis in the rat. Biochem Pharmacol 1978; 27:2577-2581.
39. Wood AJ, Villeneuve JP, Branch RA, Rogers LN, Shand DG. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. Gastroenterology 1979;76:1358-1362.
40. Wood AJ, Korhnauser DM, Wilkinson GR, Shand DG, Branch RA. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration. Clin Pharmacokinet 1978;476-487.
41. Reichen J, Hoilien C, Le M, Johes RH. Decreased uptake of taurocholate and ouabain by hepatocytes isolated from cirrhotic rat liver. HEPATOLOGY 1987;7:67-70.